Register entry
SHILPA PHARMA LIFESCIENCES LIMITED
- Registered sites
- 2
- Drug products
- 39
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufacture
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| SHILPA PHARMA LIFESCIENCES LIMITED | RaichurIndia | Analytical testing, Active ingredient (API) manufacture | 3007197995 |
| SHILPA PHARMA LIFESCIENCES LIMITED | RaichurIndia | Analytical testing, Active ingredient (API) manufacture | 3025560903 |
Catalogue
Marketed products
39Showing 39 of 39.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Abiratrone Acetate | POWDER | BULK INGREDIENT |
| - | Ambroxol Hydrochloride | POWDER | BULK INGREDIENT |
| - | Axitinib | POWDER | BULK INGREDIENT |
| - | Azacitidine | POWDER | BULK INGREDIENT |
| - | Bendamustine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Bicalutamide | POWDER | BULK INGREDIENT |
| - | Bortezomib | POWDER | BULK INGREDIENT |
| - | Busulfan | POWDER | BULK INGREDIENT |
| - | Capecitabine | POWDER | BULK INGREDIENT |
| - | Clofarabine | POWDER | BULK INGREDIENT |
| - | Cyclophosphamide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cyclophosphamide | POWDER | BULK INGREDIENT |
| - | Decitabine | POWDER | BULK INGREDIENT |
| - | Dimethyl Fumarate | POWDER | BULK INGREDIENT |
| - | Erlotinib Hydrochloride | POWDER | BULK INGREDIENT |
| - | Fingolimod Hydrochloride | POWDER | BULK INGREDIENT |
| - | Gemcitabine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Gemcitabine Hydrochloride (Process-2) | POWDER | BULK INGREDIENT |
| - | Ibrutinib | POWDER | BULK INGREDIENT |
| - | Imatinib Mesylate (IMA) | POWDER | BULK INGREDIENT |
| - | Imatinib Mesylate (IMN) | POWDER | BULK INGREDIENT |
| - | Irinotecan Hydrochloride Trihydrate | POWDER | BULK INGREDIENT |
| - | Lenvatinib Mesylate | POWDER | BULK INGREDIENT |
| - | Liraglutide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Melphalan Hydrochloride | POWDER | BULK INGREDIENT |
| - | Nifedipine | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Nifedipine | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Oxaliplatin | POWDER | BULK INGREDIENT |
| - | Pemetrexed Disodium | POWDER | BULK INGREDIENT |
| - | Phenylephrine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Pirfenidone | POWDER | BULK INGREDIENT |
| - | Prucalopride Succinate | POWDER | BULK INGREDIENT |
| - | Semaglutide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Sermorelin Acetate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Sunitinib Malate | POWDER | BULK INGREDIENT |
| - | TEMOZOLOMIDE | POWDER | BULK INGREDIENT |
| - | Tranexamic Acid | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Tranexamic Acid | POWDER | BULK INGREDIENT |
| - | Zoledronic Acid | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.